Jeffrey N. Joyce
Affiliations: | Arizona State University, Tempe, AZ, United States |
Area:
Neuroscience BiologyGoogle:
"Jeffrey Joyce"Mean distance: 53433
Children
Sign in to add trainee| Steven P. Presgraves | grad student | 2004 | Arizona State |
| Bethany S. Neal-Beliveau | post-doc | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Iarkov AV, Der TC, Joyce JN. (2010) Age-related differences in MK-801 induced behaviors in dopamine D3 receptor knock out mice. European Journal of Pharmacology. 627: 177-84 |
| Yarkov AV, Der TC, Joyce JN. (2010) Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor. European Journal of Pharmacology. 627: 167-72 |
| Mastroeni D, Grover A, Leonard B, et al. (2009) Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiology of Aging. 30: 1805-17 |
| Bychkov ER, Gurevich VV, Joyce JN, et al. (2008) Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia Neurobiology of Aging. 29: 379-396 |
| Rogers J, Mastroeni D, Leonard B, et al. (2007) Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? International Review of Neurobiology. 82: 235-46 |
| Joyce JN, Millan MJ. (2007) Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Current Opinion in Pharmacology. 7: 100-5 |
| Joyce JN, Millan MJ. (2005) Dopamine D3 receptor antagonists as therapeutic agents. Drug Discovery Today. 10: 917-25 |
| Ueda S, Sakakibara S, Nakadate K, et al. (2005) Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E. Neuroscience Letters. 380: 252-6 |
| Presgraves SP, Borwege S, Millan MJ, et al. (2004) Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells. Experimental Neurology. 190: 157-70 |
| Joyce JN, Woolsey C, Ryoo H, et al. (2004) Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. Bmc Biology. 2: 22 |